| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Hans van Houte is Chief Financial Officer at NRIX. From February 2021 to October 2026, the filings on record show 0 open-market purchases and 36 sales. Hans van Houte's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Historically, Hans van Houte's trades have earned a middling insider score of 56/100 across 32 rated trades. Over a 12-month horizon, 52.0% of those trades were profitable, with an average 12-month return of -19.2%.
The NRIX filings lean toward selling, a net 207,123 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 3,499 | $12.83 | $44,878.17 | -4.9% | +71.9% | -11.5% | |
| Apr 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,387 | $12.04 | $16,702.53 | -1.9% | +76.8% | -4.1% | |
| Feb 16, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 6,812 | $10.02 | $68,222.86 | -9.1% | +56.0% | +78.2% | |
| Jan 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,671 | $7.99 | $13,351.62 | -2.2% | +56.1% | +145.9% | |
| Dec 20, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 3,541 | $10.00 | $35,420.98 | -4.7% | +29.6% | +103.9% | |
| Dec 19, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 10,906 | $10.00 | $109,092.72 | -12.6% | +29.3% | +103.8% | |
| Oct 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,080 | $5.20 | $5,613.19 | -1.2% | +49.7% | +330.6% | |
| Jul 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,245 | $9.65 | $12,020.10 | -1.5% | -45.8% | +113.9% | |
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 721 | $9.88 | $7,120.81 | -0.9% | -1.9% | +21.4% | |
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 924 | $11.78 | $10,884.35 | -1.2% | -16.6% | -32.7% |